Success stories
Diadema Farmaceutici
In October 2024, we assisted Diadema Farmaceutici in a major capital strengthening transaction to support the start-up’s research and development projects.
To meet the needs of different types of investors, the company issued two different categories of equity financial instruments: convertible and redeemable at maturity.
Pierpaolo Vannucci Advisors worked alongside the company to draft the relevant issuance regulations for the two types of SFPs, ensuring that the terms and conditions complied with current regulations and met the flexibility required by investors.
Our support included a thorough analysis of the optimal financial structure, the identification of protection clauses for the issuing company, and the definition of the capital and administrative rights attached to the participatory financial instruments.
Specifically:
Convertible SFPs: designed to allow investors to convert their credit into equity in the company, facilitating an entry into the company’s capital in the event of significant growth.
Redeemable at Maturity SFPs: designed to attract more conservative investors by providing repayment of principal and a fixed return, thus reducing perceived risk.
This transaction represents a strategic step for Diadema Farmaceutici, allowing it to strengthen its ability to invest in innovative projects.
